(P04.5) Fetus and newborn affected by maternal use of nutritional chemical substances

More details coming soon

Icon
328 392 in individuals diagnosis fetus and newborn affected by maternal use of nutritional chemical substances confirmed
Icon
2 715 deaths with diagnosis fetus and newborn affected by maternal use of nutritional chemical substances
Icon
1% mortality rate associated with the disease fetus and newborn affected by maternal use of nutritional chemical substances

Diagnosis fetus and newborn affected by maternal use of nutritional chemical substances is diagnosed Men are 5.67% more likely than Women

173 513

Men receive the diagnosis fetus and newborn affected by maternal use of nutritional chemical substances

2 715 (1.6 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
154 879

Women receive the diagnosis fetus and newborn affected by maternal use of nutritional chemical substances

0 (less than 0.1%)

Died from this diagnosis.

Risk Group for the Disease fetus and newborn affected by maternal use of nutritional chemical substances - Men and Women aged 0

Icon
In Men diagnosis is most often set at age 0-1
Icon
Less common in men the disease occurs at Age 0-95+Less common in women the disease occurs at Age 0-5, 10-95+
Icon
In Women diagnosis is most often set at age 0-1, 5-9

Disease Features fetus and newborn affected by maternal use of nutritional chemical substances

Icon
Absence or low individual and public risk
Icon

Fetus and newborn affected by maternal use of nutritional chemical substances - what does this mean

Fetus and newborns affected by maternal use of nutritional chemical substances occurs when the mother consumes certain medications, such as antibiotics, vitamins, and other nutritional supplements, during pregnancy that can affect the fetus or newborn. these substances can cross the placenta and enter the fetal circulation, leading to adverse effects on the developing fetus or newborn.

What happens during the disease - fetus and newborn affected by maternal use of nutritional chemical substances

The pathogenesis of fetus and newborn affected by maternal use of nutritional chemical substances is related to the fact that these substances can pass through the placenta from the mother to the fetus, and can interfere with the normal development of the fetus. the substances can cause a range of physical and mental health problems, including birth defects, developmental delays, and even death.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Obtain a detailed history of the mother's use of nutritional chemical substances.
  • Perform a physical examination of the fetus/newborn.
  • Evaluate the mother's nutritional status.
  • Order laboratory tests to assess the presence of toxic substances in the mother's blood and/or urine.
  • Perform genetic testing to detect any chromosomal abnormalities.
  • Perform imaging studies to identify any structural abnormalities.
  • Perform fetal monitoring to assess the fetus's health.
  • Evaluate the newborn's vital signs and physical development.
  • Perform a complete blood count (CBC) to assess for anemia or infection.
  • Order additional tests as indicated by the history and physical examination.

Treatment and Medical Assistance

Main Goal: To provide the fetus and newborn with the necessary nutrients to ensure healthy development.
  • Provide prenatal vitamins for the mother to ensure proper nutrition.
  • Provide the mother with dietary guidance to ensure that she is consuming the right nutrients.
  • Monitor the mother's health and the baby's development during pregnancy.
  • Administer tests to detect any potential risks or health issues.
  • Provide the newborn with proper nutrition after birth.
  • Monitor the newborn's health and development.
  • Provide appropriate medical interventions if needed.
  • Provide psychological support for the mother and the newborn.
Icon
9 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Fetus and newborn affected by maternal use of nutritional chemical substances - Prevention

Prevention of this disease involves educating pregnant women on the risks of using nutritional chemical substances and encouraging them to seek medical advice before taking any supplements or medications. it is also important to provide pregnant women with access to healthy food and nutrition information to ensure they are getting the necessary nutrients for a healthy pregnancy.

Specified forms of the disease

(K66.0) Peritoneal adhesions
(K66.1) Haemoperitoneum
(K66.8) Other specified disorders of peritoneum
(K66.9) Disorder of peritoneum, unspecified